Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check2 days agoChange DetectedAn updated citation entry is reflected for a referenced paper related to multiple myeloma, with the previously shown erratum/correction text removed. The page also shows an updated site/application revision number.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded 'Multiple myeloma' and 'MedlinePlus Genetics' related topics, and updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded the Dimopoulos et al. 2007 NEJM article to Publications. Removed the Erratum for that article (2009) from the References.SummaryDifference0.0%

- Check30 days agoChange DetectedRemoved the Multiple myeloma topic and related resources, including MedlinePlus Genetics, from the page's topics/related resources.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded related topics for Multiple Myeloma and MedlinePlus Genetics, including the International uniform response criteria citation. Updated the revision to v3.5.0 and removed the older Leukemia 2006 erratum reference.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.